NIH Funding Opportunities and Notices for The Week Ending04-03-2020

Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
(PA-20-162)
National Institutes of Health
National Center for Complementary and Integrative Health
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional)
(PA-20-163)
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
Application Receipt Date(s): See the competitive revision NOSI for any applicable Application Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional)
(PAR-20-152)
National Eye Institute
Application Receipt Date(s): April 20, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
(PAR-20-153)
National Institute of General Medical Sciences
Application Receipt Date(s): July 14, 2020; July 13, 2021; July 13, 2022,by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
(PAR-20-154)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020.
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
(PAR-20-155)
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional)
(PAR-20-156)
National Institute on Aging
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020.
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
(PAR-20-157)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 5, 2020
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)
(PAR-20-158)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
(PAR-20-159)
National Institute of Mental Health
National Institute on Aging
Application Receipt Date(s): Standard dates apply. The first standard due date for this FOA is June 16, 2020
Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed)
(PAR-20-161)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): September 14, 2020, March 17, 2021, March 17, 2022, March 17, 2023
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)
(PAR-20-164)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): July 14, 2020, July 14, 2021, July 14, 2022
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
(PAS-20-160)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply.
Tuberculosis Research Units (U19 Clinical Trial Optional)
(RFA-AI-20-020)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): September 28, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Treatment of Acute Dental Pain (U01) Clinical Trials Not Allowed
(RFA-FD-20-029)
Food and Drug Administration
Application Receipt Date(s): June 1, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Drug Development Science Support (U01) Clinical Trials Optional
(RFA-FD-20-033)
Food and Drug Administration
Application Receipt Date(s): June 8, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Cooperative Agreement to Support FDA Land and Water Initiative (U01) Clinical Trial Not Allowed
(RFA-FD-20-034)
Food and Drug Administration
Application Receipt Date(s): June 1, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
Intellectual and Developmental Disabilities Reserch Centers [IDDRC] FY 2021 (P50 Clinical Trial Optional)
(RFA-HD-21-009)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): August 14, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Child Health Research Career Development Award (CHRCDA) Program (K12 Clinical Trial Not Allowed)
(RFA-HD-21-017)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): July 30, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
BRAIN Initiative: Exploratory Team-Research BRAIN Circuit Programs - eTeamBCP (U01 Clinical Trials Optional)
(RFA-NS-20-029)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
Application Receipt Date(s): July 14, 2020 and June 15, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.